KIP Global Pharma Private Equity Fund
Sector-specific private equity fund by Korea Investment Partners targeting pharmaceuticals, semiconductors, and software investments in South Korea.
KIP Global Pharma Private Equity Fund is headquartered in Seoul, South Korea, has 5 recorded investments, and includes 511 companies in its recorded portfolio.
- Headquarters
- Seoul, South Korea
- Website
- partners.koreainvestment.com
- Portfolio Companies
- 511
- Total Investments
- 5
- Last Investment
- Dec 2025
- Geographic Focus
- Asia, South Korea
Indexed holds 511 portfolio companies and 5 funding rounds for this investor. The full record is or through the API.
Investment Thesis
KIP Global Pharma Private Equity Fund is a Venture Capital firm based in Seoul, South Korea. It has made 5 investments, including Elisigen, Philoptics and J&John. Focus areas include Biotech and Healthcare.
Portfolio511
Showing 48 of 511 recorded portfolio companies. Preview limited to 250 companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 266 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Corporate VC ×3 · Accelerator ×2 · 5 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/kip-global-pharma-private-equity-fund"><img src="https://indexed.vc/api/badge/investor/kip-global-pharma-private-equity-fund" alt="KIP Global Pharma Private Equity Fund on Indexed.vc" width="260" height="76" /></a>